Tenax Therapeutics, Inc. · NASDAQ:TENX

T. Rowe Price Associates Inc reported a 17.20% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 7, 2026

T. Rowe Price Associates Inc reported a 17.20% stake in Tenax Therapeutics, Inc., 2,951,116 shares, as a passive investor on Mar 31, 2026. Filed May 7, 2026 (Schedule 13G/A).

Stake
17.20%
Shares
2,951,116
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.17.20%2,951,116

Source

View original at SEC

Related